Castle Biosciences, Inc. (CSTL)

USD 21.67

(1.93%)

Long Term Debt Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual long term debt in 2023 was 14.19 Million USD , up 23.11% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly long term debt in 2024 Q1 was 10 Million USD , down 0.0% from previous quarter.
  • Castle Biosciences, Inc. reported annual long term debt of 11.53 Million USD in 2022, up 67.14% from previous year.
  • Castle Biosciences, Inc. reported annual long term debt of 6.9 Million USD in 2021, down 0.0% from previous year.
  • Castle Biosciences, Inc. reported quarterly long term debt of 10 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Castle Biosciences, Inc. reported quarterly long term debt of 10 Million USD for 2024 Q2, up 0.08% from previous quarter.

Annual Long Term Debt Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Long Term Debt of Castle Biosciences, Inc. (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 14.19 Million USD 23.11%
2022 11.53 Million USD 67.14%
2021 6.9 Million USD 0.0%
2020 - USD -100.0%
2019 19.28 Million USD -21.27%
2018 24.49 Million USD 39.18%
2017 17.6 Million USD 0.0%

Peer Long Term Debt Comparison of Castle Biosciences, Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD -361.874%
Applied DNA Sciences, Inc. 739.16 Thousand USD -1820.824%
Aspira Women's Health Inc. 1.43 Million USD -892.867%
Biodesix, Inc. 35.22 Million USD 59.693%
BioNexus Gene Lab Corp. 98.76 Thousand USD -14275.829%
bioAffinity Technologies, Inc. 1.11 Million USD -1169.415%
bioAffinity Technologies, Inc. 1.11 Million USD -1169.415%
Bionano Genomics, Inc. 7.17 Million USD -97.882%
CareDx, Inc 28.27 Million USD 49.791%
Check-Cap Ltd. - USD -Infinity%
DarioHealth Corp. 24.59 Million USD 42.263%
Exact Sciences Corporation 2.47 Billion USD 99.426%
Fulgent Genetics, Inc. 10.11 Million USD -40.421%
Guardant Health, Inc. 1.13 Billion USD 98.755%
ICON Public Limited Company 3.66 Billion USD 99.613%
IDEXX Laboratories, Inc. 622.88 Million USD 97.721%
Illumina, Inc. 1.48 Billion USD 99.046%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -17358.561%
iSpecimen Inc. 29.13 Thousand USD -48640.13%
Standard BioTools Inc. 3.98 Million USD -256.465%
MDxHealth SA 35.56 Million USD 60.078%
23andMe Holding Co. 67.84 Million USD 79.073%
Medpace Holdings, Inc. 142.12 Million USD 90.01%
Myriad Genetics, Inc. 130.9 Million USD 89.154%
Mainz Biomed B.V. 2.19 Million USD -546.572%
ENDRA Life Sciences Inc. 192.06 Thousand USD -7292.405%
NeoGenomics, Inc. 606.06 Million USD 97.657%
Neogen Corporation 888.39 Million USD 98.402%
Inotiv, Inc. 399.4 Million USD 96.445%
Natera, Inc. 282.94 Million USD 94.982%
OpGen, Inc. 2.02 Million USD -602.309%
OPKO Health, Inc. 222.03 Million USD 93.605%
Psychemedics Corporation 945 Thousand USD -1402.434%
Prenetics Global Limited 867.21 Thousand USD -1537.195%
Prenetics Global Limited 867.21 Thousand USD -1537.195%
Precipio, Inc. 106 Thousand USD -13294.34%
Personalis, Inc. 1.23 Million USD -1050.567%
RadNet, Inc. 812.06 Million USD 98.252%
Sera Prognostics, Inc. 840 Thousand USD -1590.238%
Sotera Health Company 2.22 Billion USD 99.362%
Neuronetics, Inc. 59.28 Million USD 76.05%
Star Equity Holdings, Inc. 1.14 Million USD -1140.0%
Star Equity Holdings, Inc. 1.14 Million USD -1140.0%
Trinity Biotech plc 54.65 Million USD 74.021%
T2 Biosystems, Inc. 6.59 Million USD -115.186%
Twist Bioscience Corporation 79.17 Million USD 82.067%
Exagen Inc. 19.23 Million USD 26.171%